{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:56:56Z","timestamp":1792000616650,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":3959,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1093\/bja\/ael344","type":"journal-article","created":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T19:02:01Z","timestamp":1169665321000},"page":"246-254","source":"Crossref","is-referenced-by-count":108,"title":["Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers \u2020"],"prefix":"10.1016","volume":"98","author":[{"given":"B.A.","family":"Chizh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"G\u00f6hring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tr\u00f6ster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.K.","family":"Quartey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schmelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Koppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/bja\/ael344_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.aco.0000182557.09809.5e","article-title":"Diagnosis and treatment of neuropathic pain","volume":"18","author":"Wallace","year":"2005","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1093\/bja\/ael344_bib2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1093\/bja\/ael344_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0165-6147(00)01502-9","article-title":"NK1 (substance P) recepctor antagonists\u2013why are they not analgesic in humans?","volume":"21","author":"Hill","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1093\/bja\/ael344_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(98)00048-3","article-title":"The induction of pain: an integrative review","volume":"57","author":"Millan","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1093\/bja\/ael344_bib5","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"10.1093\/bja\/ael344_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/s0304-3959(03)00006-x","article-title":"Translation of symptoms and signs into mechanisms in neuropathic pain","volume":"102","author":"Jensen","year":"2003","journal-title":"Pain"},{"key":"10.1093\/bja\/ael344_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(01)01303-6","article-title":"Pathobiology of neuropathic pain","volume":"429","author":"Zimmermann","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1093\/bja\/ael344_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000542-200108000-00022","article-title":"A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine","volume":"95","author":"Koppert","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/ael344_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1152\/jn.01136.2002","article-title":"Central origin of secondary mechanical hyperalgesia","volume":"90","author":"Klede","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1093\/bja\/ael344_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1213\/01.ANE.0000132995.35119.99","article-title":"The effect of intravenous infusion of adenosine on electrically-evoked hyperalgesia in a healthy volunteer model of central sensitization","volume":"99","author":"Chizh","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1093\/bja\/ael344_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pain.2005.06.030","article-title":"Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model","volume":"118","author":"Koppert","year":"2005","journal-title":"Pain"},{"key":"10.1093\/bja\/ael344_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pain.2003.12.017","article-title":"The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans","volume":"108","author":"Koppert","year":"2004","journal-title":"Pain"},{"issue":"Suppl. 37","key":"10.1093\/bja\/ael344_bib13","first-page":"pA4","article-title":"Validation of the electrical hyperalgesia model in human volunteers: Effects of oral pregabalin and the NK1 antagonist aprepitant","volume":"23","author":"Koppert","year":"2006","journal-title":"Eur J Anaesthesiol"},{"key":"10.1093\/bja\/ael344_bib14","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1093\/bja\/ael344_bib15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.1093\/bja\/ael344_bib16","first-page":"pA225","article-title":"The L-754 0Psg: The substance P receptor antagonist L-754,030 (MK-0869) is ineffective in the treatment of postherpetic neuralgia","volume":"50","author":"Block","year":"1998","journal-title":"Neurology"},{"key":"10.1093\/bja\/ael344_bib17","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/cncr.11320","article-title":"Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting","volume":"97","author":"Chawla","year":"2003","journal-title":"Cancer"},{"key":"10.1093\/bja\/ael344_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.biopsych.2004.02.007","article-title":"Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant","volume":"55","author":"Bergstrom","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1093\/bja\/ael344_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpain.2005.02.003","article-title":"Quantitative sensory testing. a comprehensive protocol for clinical trials","volume":"10","author":"Rolke","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1093\/bja\/ael344_bib20","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/00000542-200412000-00021","article-title":"Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia","volume":"101","author":"Gottrup","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/ael344_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000542-200307000-00025","article-title":"Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans","volume":"99","author":"Koppert","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/ael344_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain. evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"key":"10.1093\/bja\/ael344_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00000542-200207000-00015","article-title":"Gabapentin suppresses cutaneous hyperalgesia following heat-capsaicin sensitization","volume":"97","author":"Dirks","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1093\/bja\/ael344_bib24","first-page":"313","article-title":"Discrepant results from preclinical and clinical studies on the potential of substance P-receptor antagonist compounds as analgesics","volume":"Volume 16","author":"Boyce","year":"2000"},{"key":"10.1093\/bja\/ael344_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00002826-200101000-00004","article-title":"Dose-response study of the analgesic effect of lanepitant in patients with painful diabetic neuropathy","volume":"24","author":"Goldstein","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1093\/bja\/ael344_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mcp.2000.105243","article-title":"Study of the analgesic effect of lanepitant in patients with osteoarthritis pain","volume":"67","author":"Goldstein","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/bja\/ael344_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0165-6147(99)01396-6","article-title":"Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists","volume":"20","author":"Rupniak","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1093\/bja\/ael344_bib28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00003495-200464070-00013","article-title":"Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting","volume":"64","author":"Dando","year":"2004","journal-title":"Drugs"},{"key":"10.1093\/bja\/ael344_bib29","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1200\/JCO.2003.01.095","volume":"21","author":"Hesketh","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/bja\/ael344_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1586\/14737175.5.6.823","article-title":"Combination pharmacotherapy for neuropathic pain: current evidence and future directions","volume":"5","author":"Gilron","year":"2005","journal-title":"Expert Rev Neurother"},{"key":"10.1093\/bja\/ael344_bib31","first-page":"7","article-title":"Clinical pharmacology and rationale of analgesic combinations","volume":"28","author":"Desmeules","year":"2003","journal-title":"Eur J Anaesthesiol Suppl"},{"key":"10.1093\/bja\/ael344_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pain.2004.10.008","article-title":"A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy","volume":"113","author":"Gilron","year":"2005","journal-title":"Pain"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217355332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091217355332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bja\/article-pdf\/98\/2\/246\/842734\/ael344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T13:24:54Z","timestamp":1547040294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091217355332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0007091217355332"],"URL":"https:\/\/doi.org\/10.1093\/bja\/ael344","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}